UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Ametek
AME
|
+$778M |
| 2 |
Microsoft
MSFT
|
+$432M |
| 3 |
Amazon
AMZN
|
+$423M |
| 4 |
Apple
AAPL
|
+$190M |
| 5 |
Prologis
PLD
|
+$168M |
Top Sells
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$510M |
| 3 |
ConocoPhillips
COP
|
+$381M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.72% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
HUB Group
HUBG
$2.23B
| $2.7M | ﹤0.01% |
67,888
+2,172
| +3% | +$86.3K |
|
1352
Nurix Therapeutics
NRIX
$688M
| $2.7M | ﹤0.01% |
245,496
+14,904
| +6% | +$164K |
|
1353
Red Rock Resorts
RRR
$3.65B
| $2.68M | ﹤0.01% |
67,107
+2,027
| +3% | +$81.1K |
|
1354
International Seaways
INSW
$2.33B
| $2.67M | ﹤0.01% |
72,072
-43,550
| -38% | -$1.61M |
|
1355
Brink's
BCO
$4.88B
| $2.66M | ﹤0.01% |
49,531
+445
| +0.9% | +$23.9K |
|
|
EVA
1356
DELISTED
Enviva Inc.
EVA
| $2.64M | ﹤0.01% |
49,874
+13,278
| +36% | +$703K |
|
1357
Schneider National
SNDR
$4.22B
| $2.64M | ﹤0.01% |
112,772
+5,960
| +6% | +$139K |
|
1358
Corcept Therapeutics
CORT
$7.61B
| $2.64M | ﹤0.01% |
129,904
-3,057
| -2% | -$62.1K |
|
|
PDCO
1359
DELISTED
Patterson Companies, Inc.
PDCO
| $2.62M | ﹤0.01% |
93,539
+11,453
| +14% | +$321K |
|
1360
Itron
ITRI
$5.47B
| $2.61M | ﹤0.01% |
51,479
-102
| -0.2% | -$5.17K |
|
1361
Roivant Sciences
ROIV
$9.68B
| $2.61M | ﹤0.01% |
326,042
+53,493
| +20% | +$427K |
|
1362
J&J Snack Foods
JJSF
$2.03B
| $2.6M | ﹤0.01% |
17,341
| – | – |
|
1363
Northwest Bancshares
NWBI
$1.83B
| $2.6M | ﹤0.01% |
185,623
+30,958
| +20% | +$433K |
|
1364
Marqeta
MQ
$2.62B
| $2.59M | ﹤0.01% |
424,018
-243,145
| -36% | -$1.49M |
|
1365
PTC Therapeutics
PTCT
$4.92B
| $2.59M | ﹤0.01% |
67,869
-194,100
| -74% | -$7.41M |
|
|
AXNX
1366
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.58M | ﹤0.01% |
41,324
+653
| +2% | +$40.8K |
|
1367
Alight
ALIT
$1.94B
| $2.58M | ﹤0.01% |
308,233
| – | – |
|
1368
International Bancshares
IBOC
$4.42B
| $2.57M | ﹤0.01% |
56,135
+4,625
| +9% | +$212K |
|
1369
Quaker Houghton
KWR
$2.44B
| $2.57M | ﹤0.01% |
15,379
+1,964
| +15% | +$328K |
|
1370
Graham Holdings Company
GHC
$5.11B
| $2.57M | ﹤0.01% |
4,248
| – | – |
|
1371
WesBanco
WSBC
$3.05B
| $2.56M | ﹤0.01% |
69,334
+9,155
| +15% | +$339K |
|
1372
APi Group
APG
$14.7B
| $2.56M | ﹤0.01% |
204,219
+7,836
| +4% | +$98.3K |
|
1373
Edgewell Personal Care
EPC
$1.02B
| $2.56M | ﹤0.01% |
66,348
-2,796
| -4% | -$108K |
|
|
ISEE
1374
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.56M | ﹤0.01% |
119,397
+8,590
| +8% | +$184K |
|
1375
TripAdvisor
TRIP
$2.05B
| $2.55M | ﹤0.01% |
141,988
+16,719
| +13% | +$301K |
|